Fu Gui

7PUBLICATIONS
43CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 17, 2025
cGAS restricts PARP1-mediated microhomology-mediated end joining by suppressing poly-ADP-ribosylation.

Haibo Yang, Boya Gao, Bo Wu

|Sep 17, 2025
SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations.

Wenlong Sun, Weining Weng, Jing Shi

|Jan 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.

Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara

|Oct 10, 2022
The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK.

Chen-Song Zhang, Mengqi Li, Yu Wang

|Feb 18, 2022
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer.

Chenkui Miao, Takuya Tsujino, Tomoaki Takai

Pageof 2